Affymax (AFFY) says that in connection with ongoing restructuring efforts, it's terminating John...


Affymax (AFFY) says that in connection with ongoing restructuring efforts, it's terminating John Orwin's tenure as CEO effective tomorrow. The board will be replacing him, as well as a number of other company officers, with representatives from its restructuring firm, The Brenner Group, in the coming weeks. Orwin will remain on the Board of Directors. Shares +0.7% AH.

From other sites
Comments (2)
  • christiananick
    , contributor
    Comment (1) | Send Message
     
    If this company can turn this around, it would be the greatest thing since sliced bread. Being involved on the other side of medical procedure, one thing that I have seen, is incompetence throughout the nursing careers. Shortcuts are being taken with peoples lives. And they want to blame the medicine and not the administrators of the medicine. Good Luck Affy
    14 May 2013, 10:47 PM Reply Like
  • 29YOUWISH
    , contributor
    Comments (3) | Send Message
     
    I agree, listen to all the medicine side effects on TV commercials or read the side effects and there are not many out there that do not have serious side effects. I really feel this company will turn itself around.
    14 May 2013, 11:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs